How to tell the story of "win win together" well?

"Last year, when we held the first forum, we invited 350 people to participate Today, there are 530 people, an increase of more than 50%." Yu Gang, co-founder and executive chairman of Yaowang, lamented the changes in this year In terms of trend, Yu Gang is more willing to observe this variable in the context of Internet medicine "This industry must be expected by all In the next 10 years, the big health industry will catch up with the real estate and automobile industry and become the pillar industry of China Among them, there will be more development opportunities " On December 11, as the prelude to the 2019 Second China Internet Pharmaceutical Health Summit Forum and 1 pharmaceutical Network Partner Conference, Yu Gang first expressed his high hopes for this forum through media interview Now looking back, we have to admit that the "new health care reform" in 2019 has largely rewritten the reform process of China's medical system As one of the most influential measures, "separation of medicine" on the one hand makes the situation of excessive medical treatment contained, on the other hand, it accelerates the increasingly active competition of medical market "As a matter of fact, with the implementation of the" drug share reduction "," zero drug markup "and other subdivision policies, a large number of prescriptions and drugs are flowing out of public hospitals and into online and offline drugstores." Yu Gang pointed out that the regulatory actions can be described as "thunder and rain", which has been reflected in the "4 + 7" volume purchase, online prescription drug release and other links since this year However, the "flow out" of prescription drugs is one side of the coin, and whether the market outside the hospital can "catch up" is the other side of the coin In terms of traditional mode, domestic medicine circulation is often multi-level and fragmented At the retail end, there are 480000 retail pharmacies in China, of which the head chain drugstores account for less than 2% of the market share, but the single drugstores are scattered and become the mainstream; in the distribution channels, there are still about 14000 drug distributors, distributors, wholesalers and other enterprises It is difficult for fragmentation to form scale effect, which leads to low efficiency and opacity in the medical and health industry This brings a lot of opportunities to medical e-commerce, which uses Internet technology as a bridge "China has a high penetration of Internet equipment, with e-commerce accounting for nearly 20% of total retail sales, while the U.S figure is less than 10%, and China is overtaking at a curve." As Yu Gang said in his speech, the transparency, intensification and traceability of e-commerce are helping the domestic pharmaceutical market realize a new round of virtual integration How good is the development momentum of Internet medicine? In terms of the financial statements of the third quarter of 2019 of 111 group, the parent company of 1 pharmaceutical network, its revenue in the first three quarters amounted to 2.604 billion yuan, with a year-on-year increase of 112% in net income In the third quarter, the scale of B2B business service drugstores of group 111 expanded to 210000, with a year-on-year growth of 161.5%; business revenue reached 909 million yuan, with a year-on-year growth of 229.5% However, with the development of science, technology and policy, 1 pharmaceutical network still needs to face two problems Yu Gang regards medicine and health as the "last bastion" of Internet technology One reason is the industry barrier in the field of big health "In the traditional medicine and health industry, consumers, decision makers and buyers fail to form a closed loop The decision makers are doctors, consumers are patients, and the buyers are medical insurance The three parties are independent of each other, lack effective communication and even conflict of interest, which will inevitably lead to low efficiency of resource utilization." Yu Gang explained Secondly, there are quite strict policy thresholds for Internet medicine, as can be seen from the new version of the drug administration law, which came into force on December 1, "drug production and marketing enterprises shall not directly sell prescription drugs to the public by mail or internet transaction in violation of regulations" However, Yu Gang is optimistic about this: "in the absence of detailed rules, it is too early to assess the impact of this aspect; in addition, 1 pharmaceutical network has established a compliance department, whether the introduction of industry norms or the protection of customer data, 1 pharmaceutical network will be based on the premise of compliance management." Since the company's parent company 111 group went to the U.S last year, another label has been put on the company's website - "the first share of Internet medicine going to the U.S." However, even with the outstanding results of e-commerce business, the "medical e-commerce" is not the "heart direction" of 1 pharmaceutical network No matter Yu Gang or Liu Junling, the co-founder of 1 pharmaceutical network, when speaking to the outside world, they mentioned "t2b2c ecosystem" more In brief, this ecosystem is composed of pharmaceutical enterprises, hospitals, doctors, pharmacies, insurance and other different roles, and 1 pharmaceutical network is in the position of link and technology empowerment "We are definitely not a vertical e-commerce," Yu Gang pointed out "1 pharmaceutical network empowers participants in the ecosystem through technology For example, for drugstores, no matter how the Internet develops, online and offline businesses must coexist in the future So, combining the advantages of "online 24-hour service" and "offline direct communication with customers" becomes an inevitable demand " Liu Junling takes "1 medicine city" as an example At present, this business has achieved the coverage of 31 provinces, municipalities and autonomous regions "New retail can not be separated from people, goods and markets, and the" 1 medicine city "is to create a future pharmacy with smart files, smart medicine and smart b-end through technology empowerment." Liu Junling added that with the ability of big data, "1 drug city" can help drugstores to realize category management and graft nearly 300 thousand varieties they have onto drugstores; secondly, the inventory management ability of drugstores will be greatly improved; finally, with the help of the system platform of "1 drug city", drugstores can extend their customer management ability.